Skip to content

Howard Hughes Medical Institute: UBER position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Howard Hughes Medical Institute on UBER, newest first. How the timeline and the estimate are built.

Howard Hughes Medical Institute held 28,895 UBER shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 28,895 shares
    Change vs previous 13F 0 shares

    0.47% of the 13F portfolio, value $2,085,063.

    13F-HR 0001193125-26-350254 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 28,895 shares
    Change vs previous 13F +28,448 shares

    0.5% of the 13F portfolio, value $2,078,417.

    13F-HR 0001193125-26-225362 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 447 shares
    Change vs previous 13F -1 shares

    0.02% of the 13F portfolio, value $36,524.

    13F-HR 0001193125-26-052983 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 448 shares
    Change vs previous 13F -3 shares

    0.03% of the 13F portfolio, value $43,891.

    13F-HR 0001193125-25-281376 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 451 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $42,078.

    13F-HR 0000950123-25-007937 filed by Howard Hughes Medical Institute
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).